Gene · 6614
Papers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,964
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients. | Cancer Res Treat | 2026 | 40744814 | PubTator, text mining | PubMed |
| Siglecs: From Biomodulation to Immunotherapy. | Curr Protein Pept Sci | 2026 | 40605153 | PubTator, text mining | PubMed |
| Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy. | Asian J Pharm Sci | 2025 | 41809255 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| Age- and Sex-Dependent Variation in the Type I Interferon Signature of Healthy Individuals. | Medicina (Kaunas) | 2025 | 41470231 | PubTator, text mining | PubMed |
| CellScope: high-performance cell atlas workflow with tree-structured representation. | Nat Commun | 2025 | 41469386 | PubTator, text mining | PubMed |
| Bone marrow-derived CD169+ macrophages promote autoimmune hepatitis by recruiting CCR2+ monocytes via secreting CCL12. | Exp Mol Med | 2025 | 41429897 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Reveals Novel Tumor Populations and Their Interplay with the Immune Microenvironment in a Pleomorphic Rhabdomyosarcoma. | Int J Mol Sci | 2025 | 41373578 | PubTator, text mining | PubMed |
| Immune transcriptomic changes in Australian Gulf War veterans. | PLoS One | 2025 | 41337155 | PubTator, text mining | PubMed |
| Tranexamic acid inhibits group A streptococci-mediated fibrinolysis in vitro and modulates host immune cells in vivo. | Front Immunol | 2025 | 41322414 | PubTator, text mining | PubMed |
| Enhancing antiretroviral delivery to secondary lymph nodes by targeting CD169 + macrophages with HIV-mimicking nanoparticles. | Sci Rep | 2025 | 41291024 | PubTator, text mining | PubMed |
| Immune transcriptomic differences in paediatric patients with SARS-CoV-2 compared to other lower respiratory tract infections. | bioRxiv | 2025 | 41279033 | PubTator, text mining | PubMed |
| UHRF1 restricts HCoV-229E infection through epigenetic silencing of the viral receptor APN. | Nat Commun | 2025 | 41253770 | PubTator, text mining | PubMed |
| Placenta-derived trophoblast extracellular vesicles promote CD169+ macrophage migration and suppress ovarian tumour growth. | J Transl Med | 2025 | 41250049 | PubTator, text mining | PubMed |
| Special Issue "Hematopoietic System Under Physiological Conditions and Following Hematopoietic Reconstitution or Stress: Second Edition". | Int J Mol Sci | 2025 | 41226640 | PubTator, text mining | PubMed |
| Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer. | Pathol Int | 2025 | 41221818 | PubTator, text mining | PubMed |
| Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics. | Front Immunol | 2025 | 41181158 | PubTator, text mining | PubMed |
| Mosquito salivary sialokinin reduces monocyte activation and chikungunya virus-induced inflammation via neurokinin receptors. | Nat Commun | 2025 | 41115926 | PubTator, text mining | PubMed |
| Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection. | Nanomedicine (Lond) | 2025 | 41108175 | PubTator, text mining | PubMed |
| Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE. | Front Immunol | 2025 | 41080569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6614/papers?page=6